United Therapeutics (UTHR) Change in Acquisitions & Divestments (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Change in Acquisitions & Divestments data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 113.81% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (up 135.5% YoY), and the FY2025 full-year result was $1.6 billion, up 90.42% from the prior year.
• Change in Acquisitions & Divestments grew to $1.3 billion in Q1 2026, from $485.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.1 billion in Q4 2023 to a low of -$506.6 million in Q3 2022.
• A 5-year average of $529.4 million and a median of $378.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 693.26% in 2022, while the deepest fall reached 152.86% in 2022.
• Tracing UTHR's Change in Acquisitions & Divestments over 5 years: stood at $1.0 billion in 2022, then surged by 110.01% to $2.1 billion in 2023, then plunged by 92.51% to $160.0 million in 2024, then soared by 203.44% to $485.5 million in 2025, then jumped by 169.39% to $1.3 billion in 2026.
• Business Quant data shows UTHR's Change in Acquisitions & Divestments at $1.3 billion in Q1 2026, $485.5 million in Q4 2025, and $182.5 million in Q3 2025.